Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

Journal of Clinical Oncology

Volumn 13, Issue 3, 1995, Pages 547-552

  Powles, T J ^a   Hickish, T F ^a   Makris, A ^a   Ashley, S E ^a   O'Brien, M E R ^a   Tidy, V A ^a   Casey, S ^a   Nash, A G ^a   Sacks, N ^a   Cosgrove, D ^a   MacVicar, D ^a   Fernando, I ^a   Ford, H T ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; MITOMYCIN; MITOXANTRONE; TAMOXIFEN;

ADULT; AGED; ARTICLE; ASPIRATION CYTOLOGY; BLOOD TOXICITY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0028941377     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1995.13.3.547     Document Type: Article

References (16)

1. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339:1-15, 71-85, 1992
2. Powles TJ, Smith IE: Adjuvant treatment in breast cancer. Lancet 339:423, 1992 (letter)
3. Fisher B, Wickerham D: Preoperative systemic therapy for the treatment of primary breast cancer, in Powles TJ, Smith IE (eds): Medical Management of Breast Cancer. London, United Kingdom, Martin Dunitz, 1991, pp 281-286
4. Bonadonna G, Veronesi U, Brambilla C, et al: Primary chemotherapy for resectable breast cancer. Recent Results Cancer Res 127:113-117, 1993
5. Smith IE, Jones AL, O'Brien MER, et al: Primary medical (neo-adjuvant) chemotherapy for operable breast cancer. Eur J Cancer 29:1796-1799, 1993
6. Veronesi U, Luini A, Mariani L, et al: Effect of menstrual phase on surgical treatment of breast cancer. Lancet 343:1545-1547, 1994
7. McGuire W: The optimal timing of mastectomy: Low tide or high tide? Ann Intern Med 115:401-403, 1991
8. Zajicek J, Caspersson T, Jakobsson P. Cytologic diagnosis of mammary tumors from aspiration biopsy smears. Comparison of cytologic and histologic findings in 2111 lesions and diagnostic use of cytophotometry. Acta Cytol 14:370-376, 1970
9. Powles TJ, Trott PA, Cherryman G, et al: Fine needle aspiration cytodiagnosis as a prerequisite for primary medical treatment of breast cancer. Cytopathology 2:7-12, 1991
10. Powles TJ, Jones AL, Judson IR, et al: A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) advanced breast cancer. Br J Cancer 64:406-410, 1991
11. Montes A, Powles TJ, O'Brien MER, et al: A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome. Eur J Cancer 29A: 1854-1857, 1993
12. Hayward JL, Rubens RD, Carbone PP, et al: Assessment of response to therapy in advanced breast cancer. Br J Cancer 35:292-298, 1977
13. Cosgrove DO, Bamber JC, Davy J, et al: Colour Doppler signals from breast tumours. Radiology 176:175-180, 1990
14. Falkson G, Falkson CI, Falkson H: Combination chemotherapy, in Powles TJ, Smith IE (eds): Medical Management of Breast Cancer. London, United Kingdom, Martin Dunitz, 1991, pp 139-151
15. Fisher B, Rockette H, Robidoux A, et al: Effect of preoperative therapy for breast cancer on local-region disease: First report of NSABP-18. Proc Am Soc Clin Oncol 13:64, 1994 (abstr 57)
16. Scholl SM, Fourquet A, Asselain B, et al: Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6. Eur J Cancer 30A:645-652, 1994